<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02284256</url>
  </required_header>
  <id_info>
    <org_study_id>FC-005</org_study_id>
    <secondary_id>2014-000816-32</secondary_id>
    <nct_id>NCT02284256</nct_id>
  </id_info>
  <brief_title>A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery</brief_title>
  <official_title>A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical FibrocapsTM (RaplixaTM) and Tachosil® in Surgical Hemostasis During Hepatic Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mallinckrodt</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mallinckrodt</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to demonstrate the non-inferiority or superiority of
      Fibrocaps plus gelatin sponge compared to Tachosil when control of mild to moderate bleeding
      with conventional surgical techniques is ineffective or impractical.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Hemostasis (TTH)</measure>
    <time_frame>Within 5 minutes of treatment</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Surgical Bleeding</condition>
  <arm_group>
    <arm_group_label>Fibrocaps</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Human fibrinogen and thrombin powder. Single application during surgery
Other Names:
Raplixa
PRO-0601
Fibrin sealant
Device: Gelatin sponge. Single application during surgery
Other Name: Spongostan</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TachoSil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Human fibrinogen and thrombin powder. Single application during surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fibrocaps</intervention_name>
    <arm_group_label>Fibrocaps</arm_group_label>
    <other_name>Raplixa</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TachoSil</intervention_name>
    <arm_group_label>TachoSil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria (pre-surgery):

          1. Subject has signed an independent ethics committee (IEC)-approved informed consent
             document

          2. Subject is undergoing hepatic wedge resection or anatomic resection of 1 to 5
             contiguous hepatic segments, and/or other hepatic surgery, any of which may be
             combined with other surgical procedures involving the gall bladder or intestines

          3. Subject age is &gt;18 years at time of consent

          4. If female and of child-bearing potential, subject has negative pregnancy test during
             screening and is not breast-feeding

          5. If subject is a sexually active male or a sexually active female of child-bearing
             potential, subject agrees to use a medically accepted form of contraception from the
             time of consent to completion of all follow-up study visits

             Inclusion Criteria (during surgery):

          6. Presence of mild to moderate bleeding/oozing when control by conventional surgical
             techniques, including but not limited to suture, ligature and cautery is ineffective
             or impractical

          7. Absence of intra-operative complications other than bleeding which, in the opinion of
             the investigator, may interfere with the assessment of efficacy or safety

          8. Approximate TBS surface area of ≤ 100 cm^2

        Exclusion Criteria:

          1. Subject has known hypersensitivity to Fibrocaps or any of its components

          2. Subject has known allergy to porcine gelatin

          3. Subject has known hypersensitivity to Tachosil or any of the excipients included in
             Tachosil

          4. Subject is unwilling to receive blood products

          5. Subject is having hepatic surgery due to emergency-traumatic event

          6. Subject requires extrahepatic bile duct resection (common bile duct resection or
             resection of the bile duct which leads to performing an anastomoses between the bile
             duct and small bowel) and biliary anastomosis, and/or pancreatic resections

          7. Subject has any clinically-significant coagulation disorder that may interfere with
             the assessment of efficacy or pose a safety risk to the subject according to the
             investigator, or baseline abnormalities of international normalized ratio (INR) &gt; 2.5
             or activated partial thromboplastin time (aPTT) &gt; 100 seconds during screening that
             are not explained by current drug treatment (e.g., warfarin, heparin)

          8. Subject has a platelet count &lt; 100 x10^9 PLT/L during screening

          9. Subject has medical, social or psychosocial factors that, in the opinion of the
             investigator, could impact safety or compliance with study procedures

         10. Subject is currently participating or has participated in another clinical study
             involving another investigational agent within 4 weeks of the planned date of surgery
             or is planning participation in another clinical trial within 6 weeks after surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolf Bechstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>J.W.Goethe-Universität</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin Bodingbauer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitaetsklinik Innsbruck</name>
      <address>
        <city>Innsbruck</city>
        <zip>A-6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.</name>
      <address>
        <city>Linz</city>
        <zip>A-4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitaet Wien AKH</name>
      <address>
        <city>Wien</city>
        <zip>A-1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Aachen, RWTH</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charite Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Nordwest GmbH</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>D-60488</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>J. W. Goethe Universitaetsklinik Frankfurt</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>D-60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Hamburg-Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hanover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Leipzig AoeR</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der LMU Muenchen - Campus Grosshadern</name>
      <address>
        <city>Muenchen</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Rechts der Isar Munich</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Stuttgart - Katharinenhospital (KH)</name>
      <address>
        <city>Stuttgart</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>72976</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 5, 2014</study_first_posted>
  <last_update_submitted>August 14, 2017</last_update_submitted>
  <last_update_submitted_qc>August 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

